{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T08:41:19Z","timestamp":1761986479607,"version":"build-2065373602"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.anai.2014.04.008","type":"journal-article","created":{"date-parts":[[2014,5,9]],"date-time":"2014-05-09T15:05:18Z","timestamp":1399647918000},"page":"101-107","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Patient initiation and persistence with allergen immunotherapy"],"prefix":"10.1016","volume":"113","author":[{"given":"Robert","family":"Anolik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann Marie","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiva","family":"Sajjan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felicia","family":"Allen-Ramey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"suppl","key":"10.1016\/j.anai.2014.04.008_bib1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1398-9995.2007.01548.x","article-title":"A\u00a0survey of the burden of allergic rhinitis in the USA","volume":"62","author":"Schatz","year":"2007","journal-title":"Allergy"},{"key":"10.1016\/j.anai.2014.04.008_bib2","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1001\/jama.2013.2049","article-title":"Sublingual immunotherapy for the treatment of allergic rhinoconjunctivitis and asthma: a systemic review","volume":"309","author":"Lin","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.anai.2014.04.008_bib3","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.jaci.2010.12.1106","article-title":"Allergy-related outcomes in relation to serum IgE: results from the National Health and Nutrition Examination Survey 2005\u20132006","volume":"127","author":"Salo","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2014.04.008_bib4","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jaip.2013.03.012","article-title":"Current and future directions in pediatric allergic rhinitis","volume":"1","author":"Gentile","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.anai.2014.04.008_bib5","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.jaci.2013.01.049","article-title":"Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology\/European Academy of Allergy and Clinical Immunology\/PRACTALL consensus report","volume":"13","author":"Burks","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2014.04.008_bib6","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.anai.2012.04.002","article-title":"Allergen immunotherapy practice patterns: a worldwide survey","volume":"108","author":"Ponda","year":"2012","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2014.04.008_bib7","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1542\/peds.2013-0343","article-title":"Allergen-specific immunotherapy for pediatric asthma and rhinoconjunctivitis: a systematic review","volume":"131","author":"Kim","year":"2013","journal-title":"Pediatrics"},{"year":"2013","author":"Lin","series-title":"Allergen-Specific Immunotherapy for the Treatment of Allergic Rhinoconjunctivitis and\/or Asthma: Comparative Effectiveness Review. Comparative Effectiveness Reviews no 111","key":"10.1016\/j.anai.2014.04.008_bib8"},{"key":"10.1016\/j.anai.2014.04.008_bib9","first-page":"1","article-title":"Allergen immunotherapy for allergic rhinitis and asthma","volume":"20","author":"Cox","year":"2008","journal-title":"Drug Benefit Trends"},{"key":"10.1016\/j.anai.2014.04.008_bib10","first-page":"689","article-title":"Allergen Immunotherapy","volume":"70","author":"Higgins","year":"2004","journal-title":"Am Fam Phys"},{"key":"10.1016\/j.anai.2014.04.008_bib11","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/ACI.0b013e328332b8df","article-title":"Evidence of adherence to allergen-specific immunotherapy","volume":"9","author":"Senna","year":"2009","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2014.04.008_bib12","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/WOX.0b013e3181c6c379","article-title":"Sub-lingual Immunotherapy. World Allergy Organization Position Paper 2009","volume":"2","author":"Canonica","year":"2009","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.anai.2014.04.008_bib13","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.iac.2011.03.007","article-title":"The health economics of allergen immunotherapy","volume":"31","author":"Hankin","year":"2011","journal-title":"Immunol Allergy Clin North Am"},{"issue":"suppl 1","key":"10.1016\/j.anai.2014.04.008_bib14","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaci.2010.09.034","article-title":"Allergen immunotherapy: a practice parameter third update","volume":"127","author":"Cox","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2014.04.008_bib15","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2217\/imt.12.157","article-title":"Sublingual immunotherapy for allergic rhinitis and conjunctivitis","volume":"5","author":"Passalacqua","year":"2013","journal-title":"Immunotherapy"},{"key":"10.1016\/j.anai.2014.04.008_bib16","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/MOO.0b013e328341d0bd","article-title":"Sublingual immunotherapy for allergic rhinitis: an update","volume":"19","author":"Passalacqua","year":"2011","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.anai.2014.04.008_bib17","first-page":"509","article-title":"Allergen-specific sublingual immunotherapy for respiratory allergy","volume":"15","author":"Passalacqua","year":"2001","journal-title":"Bio Drugs"},{"key":"10.1016\/j.anai.2014.04.008_bib18","doi-asserted-by":"crossref","first-page":"128","DOI":"10.4103\/1817-1737.65038","article-title":"Sublingual immunotherapy in allergic asthma: Current evidence and needs to meet","volume":"5","author":"Incorvaia","year":"2010","journal-title":"Ann Thorac Med"},{"key":"10.1016\/j.anai.2014.04.008_bib19","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S1081-1206(10)60755-7","article-title":"Duration of allergen immunotherapy in respiratory allergy: when is enough, enough?","volume":"98","author":"Cox","year":"2007","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2014.04.008_bib20","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jaci.2010.10.014","article-title":"Patient characteristics associated with allergen immunotherapy initiation and adherence","volume":"127","author":"Hankin","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2014.04.008_bib21","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1177\/014556131109000408","article-title":"Inadequate health insurance coverage: a major factor in premature discontinuation of subcutaneous immunotherapy for allergic rhinitis","volume":"90","author":"Vaswani","year":"2011","journal-title":"Ear Nose Throat J"},{"key":"10.1016\/j.anai.2014.04.008_bib22","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/ACI.0b013e3283466fcb","article-title":"Determinants of patient compliance in allergic rhinoconjunctivitis","volume":"11","author":"Koberlein","year":"2011","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2014.04.008_bib23","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.anai.2012.03.009","article-title":"Survey on immunotherapy practice patterns: dose, dose adjustments, and duration","volume":"108","author":"Larenas-Linnemann","year":"2012","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2014.04.008_bib24","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.iac.2011.05.001","article-title":"Specific allergy immunotherapy for allergic rhinitis: subcutaneous and sublingual","volume":"31","author":"Cox","year":"2011","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.anai.2014.04.008_bib25","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.anai.2012.12.014","article-title":"Perception and practice of sublingual immunotherapy among practicing allergists in the United States: a follow-up survey","volume":"110","author":"Sikora","year":"2013","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2014.04.008_bib26","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S1081-1206(10)60320-1","article-title":"ACAAI Immunotherapy and Diagnostics Committee. Perception and practice of sublingual immunotherapy among practicing allergists","volume":"101","author":"Tucker","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2014.04.008_bib27","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jaci.2007.10.026","article-title":"Allergy immunotherapy among Medicaid-enrolled children with allergic rhinitis: patterns of care, resource use, and costs","volume":"121","author":"Hankin","year":"2008","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2014.04.008_bib28","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3310\/hta17270","article-title":"A\u00a0systematic review and economic evaluation of subcutaneous and sublingual allergen immunotherapy in adults and children with seasonal allergic rhinitis","volume":"17","author":"Meadows","year":"2013","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.anai.2014.04.008_bib29","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jaci.2013.03.013","article-title":"Real-life compliance and persistence among users of subcutaneous and sublingual allergen immunotherapy","volume":"132","author":"Kiel","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2014.04.008_bib30","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1185\/03007995.2011.559538","article-title":"Medication persistence with long-term, specific grass pollen immunotherapy measured by prescription renewal rates","volume":"27","author":"Sieber","year":"2011","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.anai.2014.04.008_bib31","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1365-2222.2012.04052.x","article-title":"Adherence to pharmacological treatment and specific immunotherapy in allergic rhinitis","volume":"43","author":"Passalacqua","year":"2013","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.anai.2014.04.008_bib32","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1111\/j.1365-2222.2008.03060.x","article-title":"Sublingual immunotherapy in youngsters: adherence in a randomized clinical trial","volume":"38","author":"R\u00f6der","year":"2008","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.anai.2014.04.008_bib33","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1398-9995.2007.01451.x","article-title":"Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study","volume":"62","author":"Jacobsen","year":"2007","journal-title":"Allergy"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120614002579?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120614002579?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:09:58Z","timestamp":1761052198000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120614002579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S1081120614002579"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2014.04.008","relation":{},"ISSN":["1081-1206"],"issn-type":[{"type":"print","value":"1081-1206"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient initiation and persistence with allergen immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2014.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}